Eliksa Therapeutics, a regenerative medicine company developing novel therapeutics for a range of debilitating diseases, announced today it has launched with in
/PRNewswire/ The JVS Philadelphia Fund for Women (JVS Fund) and Ben Franklin Technology Partners of Southeastern Pennsylvania (Ben Franklin) today announced.